In comparison, a trend of increased hypothalamic–pituitary–ovarian axis (HPOA) functional disorders in PCOS-NIR and PCOS-NOW groups was observed since they had higher LH and AMH levels than PCOS-IR and PCOS-OW groups. The gene discussed is PLOD1; the disease is polycystic ovary syndrome.